Changes in Insulin Resistance Following Bariatric Surgery: Role of Caloric Restriction and Weight Loss
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
The prevalence of type 2 diabetes mellitus (T2DM) and obesity in the western world is steadily increasing. Bariatric surgery is an effective treatment of T2DM in obese patients. The mechanism by which weight loss surgery improves glucose metabolism and insulin resistance remains controversial. In this review, we propose that two mechanisms participate in the improvement of glucose metabolism and insulin resistance observed following weight loss and bariatric surgery: caloric restriction and weight loss. Nutrients modulate insulin secretion through the entero-insular axis. Fat mass participates in glucose metabolism through the release of adipocytokines. T2DM improves after restrictive and bypass procedures, and combinations of restrictive and bypass procedures in morbidly obese patients. Restrictive procedures decrease caloric and nutrient intake, decreasing the stimulation of the entero-insular axis. Gastric bypass (GBP) operations may also affect the entero-insular axis by diverting nutrients away from the proximal GI tract and delivering incompletely digested nutrients to the distal GI tract. GBP and biliopancreatic diversion combine both restrictive and bypass mechanisms. All procedures lead to weight loss and decrease in the fat mass. Decrease in fat mass significantly affects circulating levels of adipocytokines, which favorably impact insulin resistance. The data reviewed here suggest that all forms of weight loss surgery lead to caloric restriction, weight loss, decrease in fat mass and improvement in T2DM. This suggests that improvements in glucose metabolism and insulin resistance following bariatric surgery result in the short-term from decreased stimulation of the entero-insular axis by decreased caloric intake and in the long-term by decreased fat mass and resulting changes in release of adipocytokines. Observed changes in glucose metabolism and insulin resistance following bariatric surgery do not require the posit of novel regulatory mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some ways, this is reminiscent of the effects of gastric bypass surgery to rapidly alleviate insulin resistance and diabetes well before significant weight loss ensues (32).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [32]
Citations
Cites
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Pories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00011 · Cited by 2,293
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin
Asakawa, A., Inui, A., Kaga, O., Yuzuriha, H., Nagata, T., Ueno, N., Makino, S., Fujimiya, M., Niijima, A., Fujino, M. A., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.22158 · Cited by 1,177
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Cited by
Items 101–188 of 188
Is Acetylation a Metabolic Rheostat that Regulates Skeletal Muscle Insulin Action?
LaBarge, S. A., Migdal, C., & Schenk, S. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0020 · Cited by 22
“, 2001), with clinical studies demonstrating that the majority of the improvement in insulin action during weight loss, or after gastric bypass, occurs during the first week of intervention, and before substantial weight loss occurs (Assali et al., 2001; Gumbs et al., 2005; Kelley et al., 1993).”
BackgroundBariatric Surgery for Morbid Obesity: Risks and Benefits in Chronic Kidney Disease Patients
Zalesin, K. C., & McCullough, P. A. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.07.008 · Cited by 21
Trung, V. N., Yamamoto, H., Yamaguchi, T., Murata, S., Akabori, H., Ugi, S., Maegawa, H., & Tani, T. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.05.019 · Cited by 17
“[16] Gumbs AA, Modlin IM, Ballantyne GH.”
Johansson, H.-E., Haenni, A., & Zethelius, B. (2011) · Journal of Obesity · doi:10.1155/2011/273105 · Cited by 17
“Hindawi Publishing Corporation Journal of Obesity Volume 2011, Article ID 273105, 6 pages doi:10.1155/2011/273105”
InfluentialLamounier, R. N., Pareja, J. C., Tambascia, M. A., & Geloneze, B. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9098-y · Cited by 21
Weight Change as a Predictor of Incidence and Remission of Insulin Resistance
Chang, Y., Sung, E., Yun, K. E., Jung, H. S., Kim, C., Kwon, M., Cho, S., & Ryu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063690 · Cited by 16
Bariatric Surgery and Type 2 Diabetes Mellitus: Surgically Induced Remission
Tejirian, T., Jensen, C., & Dutson, E. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200420 · Cited by 18
Goto, T., Hirayama, A., Faridi, M. K., Camargo, C. A., & Hasegawa, K. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix541 · Cited by 16
“Furthermore, bariatric surgery also reverses the obesity-related increase in proinflammatory mediator levels [9] and decreases the prevalence of the obesity-related comorbidities (eg, type 2 diabetes) that are known to increase the risk of infectious diseases [10, 11, 25].”
BackgroundBehavior of Type 2 Diabetes Mellitus in Morbid Obese Patients Submitted to Gastric Bypass
Mottin, C. C., Padoin, A. V., Schroer, C. E., Barancelli, F. T., Glock, L., & Repetto, G. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9249-1 · Cited by 20
“Recent studies have probed the mechanism by which morbid obese patients control DM2 after bariatric surgery [3–15].”
BackgroundImmediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics
Meydan, C., Goldstein, N., Weiss-Shwartz, E., Lederfine, D., Goitein, D., Rubin, M., & Spivak, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1669-8 · Cited by 15
“[29].”
Treatment of type 2 diabetes mellitus with bariatric surgery
Clifton, P. M. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.23 · Cited by 15
“Some investigators, however, are not convinced that novel mechanisms are required to explain the improvements in glucose homeostasis”
BackgroundKullberg, J., Sundbom, M., Haenni, A., Fredén, S., Johansson, L., Börnert, P., Ahlström, A., Ahlström, H. K., & Karlsson, A. (2010) · Journal of Obesity · doi:10.1155/2011/959601 · Cited by 16
Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass
Elahi, D., Galiatsatos, P., Rabiee, A., Salas-Carrillo, R., Vakilipour, A., Carlson, O. D., Angeli, F. S., Shannon, R. P., Egan, J. M., & Andersen, D. K. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.07.011 · Cited by 17
“It has been suggested that exclusion of nutrients from the duodenum may result in a diminished or absent response of 1 or more duodenal hormones, which act as inhibitors of insulinotropic incretin agents, referred to as antiincretin hormones [12,18,35,37,38].”
Golpaie, A., Hosseinzadeh‐Attar, M. J., Hoseini, M., Karbaschian, Z., & Talebpour, M. (2012) · Journal of Minimally Invasive Surgical Sciences · doi:10.17795/minsurgery-2596 · Cited by 12
Jiang, H., Zhou, Y., Zhou, P., Zhang, T., Hu, J., & Bai, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.662666 · Cited by 14
Contribution of obesity to pancreatic carcinogenesis
Gumbs, A. A., Bessler, M., Milone, L., Schrope, B., & Chabot, J. A. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.11.009 · Cited by 12
“adults re now obese [6].”
BackgroundSelf-citationFrom bariatric to metabolic surgery in non-obese subjects: time for some caution
Deitel, M. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200016 · Cited by 12
Johansson, H.-E., Haenni, A., Öhrvall, M., Sundbom, M., & Zethelius, B. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9806-x · Cited by 11
Qi, Y., Wang, D., Li, F., Liu, X., Liu, C., Zhao, F., Wu, D., Wang, X., Wang, J., & Min, W. (2022) · Foods · doi:10.3390/foods11223571 · Cited by 13
“It has been shown to regulate various physiological processes associated with T2DM, such as stimulating glucose uptake in adipose tissue, muscle, and liver, in addition to promoting insulin signaling [26].”
BackgroundLong-term diabetic response to gastric bypass
Davies, S. W., Efird, J. T., Guidry, C. A., Penn, R. I., Sawyer, R. G., Schirmer, B. D., & Hallowell, P. T. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.01.047 · Cited by 13
“[38] Gumbs AA, Modlin IM, Ballantyne GH.”
Desiderio, J., Trastulli, S., Scalercio, V., Cirocchi, R., Carloni, G., Moriconi, E., Boselli, C., Noya, G., & Amilcare, P. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0308 · Cited by 11
“Gumbs et al. 22 suggested that the improvement in insulin resistance after bariatric surgery is due to the reduction of the stimulation of the enteroinsular axis induced by caloric restriction in the short term and by weight loss in the long term.”
Obesity Surgery in a 12-Year-Old – an Ecuadorian Experience
Leon, J. M., McDermott, J. W., Salcedo, I. M., Cassanello, N. A., Guzmán, S., Barriga, F., Flor, E., & Mariani, R. V. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9024-3 · Cited by 10
Middleton, A.-L. O., Byrne, J. P., & Calder, P. C. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.02.001 · Cited by 13
“However, there could be other effects of bariatric surgery that might influence blood PUFAs, for example improved insulin sensitivity [83,84] which would alter whole body lipid homeostasis influencing processes such as clearance and release of PUFAs by insulin sensitive tissues and long chain PUFA…”
Hasan, M. A., Schwartz, S. S., McKenna, V., & Ing, R. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06758-1 · Cited by 7
“Weight loss is associated with a decrease in fat mass, which, in turn, affects the levels of adipocytokines that play a role in insulin resistance and glucose metabolism [57].”
BackgroundAlam, I., Stephens, J. W., Fielding, A., Lewis, K. E., Lewis, M. J., & BAXTER, J. N. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.10.018 · Cited by 8
Plasma Polyunsaturated Fatty Acids After Weight Loss Surgery
Aslan, I., & Aslan, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804011-9.00058-3 · Cited by 7
Resolution of Diabetes After Bariatric Surgery Among Predominantly African-American Patients
Araia, M., Wood, M., Kroll, J. J., Abou‐Samra, A., & Seyoum, B. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1187-0 · Cited by 8
Preserve Common Limb in Duodenal–Jejunal Bypass Surgery Benefits Rats with Type 2-Like Diabetes
Zhang, S.-Y., Sun, X., Zheng, J.-B., Wang, W., Liu, D., Chen, N.-Z., He, S., Huo, X.-W., & Smith, W. W. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1103-z · Cited by 7
The role of obestatin in Roux-en-Y gastric bypass surgery in the obese, type 2 diabetes Zucker rat
Xu, X.-H., Wang, J., Li, L., Wang, C., Li, W., Zhang, Q., & Linghui, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.024 · Cited by 6
Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_24 · Cited by 9
Xuan, C., Huang, Z., Ran, W., Liao, G., Zha, L., & Wang, Z. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1832 · Cited by 6
“GBP may primarily contribute to the reduction of blood glucose levels in patients with T2DM rather than the control of weight (22-24).”
Koppo, K., Valle, C., Šiklová, M., Czudková, E., de Glisezinski, I., de Voorde, J. V., Langin, D., & Štich, V. (2013) · Physiological Research · doi:10.33549/physiolres.932483 · Cited by 8
“It has been suggested that the early improvement in metabolic status is associated with calorie restriction per se – eventually combined with a mild initial weight loss – while the later beneficial metabolic effects are linked to sustained weight loss only (Hensrud 2001, Gumbs et al. 2005).”
BackgroundEldar, S. M., Heneghan, H., Dan, O., Kirwan, J. P., Schauer, P. R., & Brethauer, S. A. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.019 · Cited by 6
Mor, A., Tabone, L. E., Omotosho, P. A., & Torquati, A. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-3338-0 · Cited by 7
“Si improves within days after gastric bypass surgery, likely secondary to reduced stimulation of the entero-insular axis by caloric restriction [19, 20].”
BackgroundPrevention of Cardiovascular Complications of the Metabolic Syndrome: Focus on Pharmacotherapy
Krentz, A. J. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.328 · Cited by 5
The effects of sleeve gastrectomy on hormonal regulation of glucose metabolism in Goto–Kakizaki rats
Zhu, Z., Yang, X., Wang, K., Wang, Z., Zhao, Y. W., & Yu, M. (2014) · European surgery. Supplement/European surgery · doi:10.1007/s10353-014-0270-z · Cited by 5
Janosz, K. E. N., Zalesin, K. C., Miller, W. M., McCullough, P. A., & Franklin, B. A. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0036-3 · Cited by 5
“T2DM range as high as 74% to 86% for RYGB and 33% to 80% for AGBS (Table 1). There are associated improvements of other cardiovascular risk factors, including hypertension [24], dyslipidemia [26,27], insulin resistance [ 28 ], high-sensitivity C-reactive protein levels [29], proteinuria [27,30], infl ammatory markers,…”
BackgroundDeClercq, V., Defries, D. M., Hunt, R., Taylor, C. G., & Zahradka, P. C. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch4 · Cited by 6
Lifestyle Modification Is the First Line Treatment for Type 2 Diabetes
Masuo, K. (2013) · InTech eBooks · doi:10.5772/56377 · Cited by 3
“[128] speculated that a decrease in fat mass after bariatric surgery significantly affected circulating adipocytokines, which favourably influ‐ enced insulin resistance.”
BackgroundThe Role of Laparoscopic Mini-Gastric Bypass in Management of Metabolic Syndrome
El-Husseiny, M. A., Moneim, A. A.-H. A., Abdel-Maksoud, M. A., & Hammad, K. S. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.010 · Cited by 4
Common Channel Length in Bypass Surgery Does Not Impact T2DM in Diabetic Zucker Rats
Laessle, C., Michelmichel, S., Marjanović, G., Kuesters, S., Seifert, G. J., Hopt, U. T., & Fink, J. M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2611-z · Cited by 5
Lifante, J.-C., & Inabnet, W. B. (2008) · Journal de Chirurgie · doi:10.1016/s0021-7697(08)74685-4 · Cited by 5
Weight regain after bariatric surgery: Promoters and potential predictors
Demerdash, H. M. (2021) · World Journal of Meta-Analysis · doi:10.13105/wjma.v9.i5.438 · Cited by 3
The Effect and Mechanism of Duodenal-Jejunal Bypass to Treat Type 2 Diabetes Mellitus in a Rat Model
Chen, X., Zhang, Q., Yang, Q., Huang, Z., Liao, G., & Wang, Z. (2022) · Obesity Facts · doi:10.1159/000519417 · Cited by 5
Treatments for Hypertension in Type 2 Diabetes-Non-Pharmacological and Pharmacological Measurements
Masuo, K., & Gavin, W. (2011) · InTech eBooks · doi:10.5772/20685 · Cited by 2
“[84] speculated that decrease in fat mass caused by bariatric surgery significantly affected circulating adipocytokines, which favourably impact on insulin resistance.”
BackgroundInfluentialDietary energy intake is associated with type 2 diabetes risk markers in children
Donin, A. S., Nightingale, C. M., Owen, C. G., Rudnicka, A. R., Jebb, S. A., Ambrosini, G. L., Stephen, A. M., Cook, D. G., & Whincup, P. H. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001729 · Cited by 3
Does Bariatric Surgery Improve Obesity Associated Comorbid Conditions
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_24 · Cited by 3
Adiponectin receptor fragmentation in mouse models of type 1 and type 2 diabetes
Frabutt, D. A., Stull, N. D., Piñeros, A. R., Tersey, S. A., Scheuner, D. L., Mastracci, T. L., & Pugia, M. J. (2020) · Archives of Autoimmune Diseases · doi:10.46439/autoimmune.1.002 · Cited by 3
“In contrast, lower serum levels of adiponectin are associated with T2D, cardiovascular disease, and insulin resistance, although the levels increase when T2D patients undergo post-gastric bypass surgery for visceral fat reduction [6,7].”
Esser, N., Paquot, N., & Scheen, A. J. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70161-9 · Cited by 4
Janssen, J. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052150 · Cited by 2
“This improvement often occurs well before any substantial weight loss has occurred [41–44].”
5. Metabolic Effects of Bariatric Surgery
Heneghan, H., Eldar, S. M., Brethauer, S. A., & Schauer, P. R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2347-8_5 · Cited by 2
The relationship between employment status and insulin resistance in the Korean elderly population
Park, J. M., Dong, J.-J., Lee, J., Shim, J., & Lee, Y. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-0934-9 · Cited by 3
“Lifestyle behaviors, such as exercise status [19], smoking status [20], alcohol intake [21, 22], and daily calorie intake [23], influence insulin resistance.”
BackgroundGarcía-Caballero, M., Navarrete, S., Favretti, F., Celik, A., & Castillo, D. D. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6710 · Cited by 4
Reversal of Obesity: The Quest for the Optimum Dietary Regimen
Nicoll, R. (2017) · International Journal Of Nutrition · doi:10.14302/issn.2379-7835.ijn-17-1548 · Cited by 2
“Weight loss invariably leads to reduced insulin resistance, no matter how it occurs [71].”
BackgroundTreatment of Obesity with Bariatric Surgery
Izaguirre, M., Frühbeck, G., & Catalán, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65164-4 · Cited by 3
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_19 · Cited by 2
[Questioning bariatric surgery].
Vojvodic-Hernández, I. (2009) · Revista de Gastroenterología del Perú · doi:10.47892/rgp.2009.294.475 · Cited by 4
Obesity Surgery and the Role in Treating Type 2 Diabetes Mellitus, Are We Ready for the Next Step?
Abbas, S. M. (2006) · Current Surgery · doi:10.1016/j.cursur.2005.12.011 · Cited by 1
The expanding role of nutrition in endocrinology and metabolism
Apovian, C. M., & Kushner, R. F. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000244219.45539.58 · Cited by 1
Facing Overweight and Obesity: A Guide for Mental Health Professionals
Stevens, J. R., & Stern, T. A. (2019) · Psychiatric Annals · doi:10.3928/00485713-20190109-02 · Cited by 1
Gagnière, J., Slim, K., Launay-Savary, M.-V., Raspado, O., Flamein, R., & Chipponi, J. (2011) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2011.02.003 · Cited by 1
Laparoscopic Sleeve Gastrectomy For Morbid Obesity: The Future Of Bariatric Surgery?
Guraya, S. Y., & Murshid, K. R. (2011) · doi:10.5281/zenodo.7768 · Cited by 1
“Nonetheless, the use of LSG as a bridge to more definite surgery is perhaps its most striking role (Gumbs et al., 2005).”
BackgroundInfluentialImpact of Inflammation and Innate Immunity Response in Obesity Mediated Diabetes
Pugia, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-21927-1_1 · Cited by 1
Impact of Bariatric Surgery on Type II Diabetes
Karim, M. A., Naveed, M. J., MacKay, W., & Ali, A. (2013) · Cited by 1
Effects of MGB on Type 2 Diabetes in Lower BMI Patients
Mahdy, T., & Gado, W. (2018) · Springer eBooks · doi:10.1007/978-3-319-76177-0_14 · Cited by 1
Zhang, Q., Hong, Z., Zhu, J., Zeng, C., Tang, Z., Wang, W., & Huang, H. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05604-6 · Cited by 3
Metabolic surgery in the treatment of type 2 diabetes mellitus
Cummings, D. E. (2011) · doi:10.1093/med/9780199235292.003.1416 · Cited by 1
Hipovitaminosis D y obesidad mórbida: efectos de la cirugía bariátrica
Sánchez-Hernández, J. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Treating Obesity in Chronic Kidney Disease
Burrowes, J. D. (2009) · Nutrition Today · doi:10.1097/nt.0b013e31819de33b
Type 2 Diabetes: Fueling the Surge of Cardiovascular Disease in Women
Jones, E. J., & Appel, S. J. (2008) · Nursing for Women s Health · doi:10.1111/j.1751-486x.2008.00384.x · Cited by 1
Dib, N., Tarnawski, W., Zabielski, R., Pietrzak, P., Ferenc, K., Jaworski, P., & Kiciak, A. (2013) · Gastroenterology Review · doi:10.5114/pg.2013.34180
Progress in New Markers for Diabetes Inflammation
Pugia, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-21927-1_11
Association of Severe Obesity with the Metabolic Profile of Adolescents and Adults
Teixeira, J. S. (2016) · Journal of Obesity and Weight-loss Medication · doi:10.23937/2572-4010.1510013
“This relationship leads to the hypothesis that the adipose tissue acts as an endocrine organ in the regulation of glucose metabolism and that insulin resistance (IR) plays an important role in this pathogenesis [10,11].”
BackgroundCorrelation between Body Mass Index and Homa Index in Bariatric Patients
Dejeu, P., Dejeu, V., Dejeu, D., & Bembea, M. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0004
“Other contradictory results arose when attempting to demonstrate a positive correlation between the decreased HOMA1 index (and also in the improvement in insulin sensitivity) and the weight loss after bariatric surgery [12,13].”
ResultFranciss, M. Y. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-04062019-143507
Campos, J. M., Lins, D. D. C., Silva, L. B., Guido, J., Araujo-Junior, C., Zeve, J. L. D. M., & Ferraz, Á. A. B. (2013)
Impacts of bariatric surgery on type 2 diabetes mellitus
Yassin, M. A., Merdan, I., & Al-Gazgooz, F. (2019) · The Medical Journal of Basrah University · doi:10.33762/mjbu.2019.163355
“[20] All obese patients have some level of insulin resistance and risk of development of T2DM that grows with increased weight [21,22] and about 90% of all patient with T2DM either are overweight or obese.”
BackgroundMetabolic effects of dipeptyl peptidase 4 inhibitor in type 2 diabetes
Macauley, M. (2016)
Roux-en-Y Gastric Bypass: Procedure and Outcomes
Felder, S. I., & Cunneen, S. A. (2015) · Endocrine updates · doi:10.1007/978-1-4939-2146-1_7
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_19 · Cited by 1
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_19-1
Supporting patients to achieve remission of type 2 diabetes
James, J. (2022) · Nursing Standard · doi:10.7748/ns.2022.e11949
Mechanisms of Control of Diabetes 2 with Duodenal Switch
Holihan, J. L., & Wilson, E. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-25828-2_60
Morgan, J. R. (2013) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/4484372 · Cited by 1
Pathophysiology of Insulin Resistance: Implications for Prevention
Ali, S., & Fonseca, V. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_3
Neira, G., Rodríguez, A., Gómez‐Ambrosi, J., Frühbeck, G., & Catalán, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00347-2
Echocardiographic evaluation and clinical implications of cardiac remodeling in obesity
Okushi, Y., Takahashi, T., & Kusunose, K. (2026) · Journal of Echocardiography · doi:10.1007/s12574-026-00721-6 · Cited by 1
Ashtary‐Larky, D. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00751-2
Metadata
- Authors
- Gumbs, A. A., Modlin, I. M., & Ballantyne, G. H.
- Affiliations
- Yale University (US)
- Hackensack University Medical Center (US)
- ORCID
- Gumbs, Andrew A
- Venue
- Obesity Surgery
- Published
- 2005-04
- Volume
- 15
- Issue
- 4
- Pages
- 462-473
- ISSN
- 0960-8923 (ISSN-L)
- 1708-0428
- OpenAlex
- W1980523744
- Cited by
- 188
- References
- 83
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 5 · 2017: 10 · 2016: 5 · 2015: 12 · 2014: 7 · 2013: 20 · 2012: 8
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Obesity Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- bariatric surgery, insulin resistance
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Energy Metabolism, Female, Gastric Inhibitory Polypeptide, Glucagon, Humans, Insulin Resistance, Male, Obesity, Morbid, Peptide Fragments, Prognosis, Protein Precursors, Gastric Bypass, Biomarkers, Weight Loss, Body Mass Index, Treatment Outcome, Caloric Restriction, Peptide Hormones, Glucagon-Like Peptide 1, Ghrelin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.